GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Price-to-Free-Cash-Flow

Psyence Biomedical (Psyence Biomedical) Price-to-Free-Cash-Flow : (As of Apr. 27, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Price-to-Free-Cash-Flow?

As of today (2024-04-27), Psyence Biomedical's share price is $0.8589. Psyence Biomedical does not have enough years/quarters to calculate the Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2023. Therefore GuruFocus does not calculate Price-to-Free-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Psyence Biomedical's Price-to-Free-Cash-Flow or its related term are showing as below:

PBM's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.52
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Psyence Biomedical's Free Cash Flow per Share for the six months ended in Mar. 2023 was $-0.11.


Psyence Biomedical Price-to-Free-Cash-Flow Historical Data

The historical data trend for Psyence Biomedical's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Price-to-Free-Cash-Flow Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Price-to-Free-Cash-Flow
- - -

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Price-to-Free-Cash-Flow - - -

Competitive Comparison of Psyence Biomedical's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Psyence Biomedical's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Price-to-Free-Cash-Flow falls into.



Psyence Biomedical Price-to-Free-Cash-Flow Calculation

Psyence Biomedical's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.8589/
=

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Psyence Biomedical  (NAS:PBM) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Psyence Biomedical Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines